CHKS launches MRSA Diagnostic Audit

Main Category: MRSA / Drug Resistance
Article Date: 09 Apr 2005 - 0:00 PDT

email to a friend   printer friendly   opinions  

CHKS programme identifies the incidence of infection, improves data quality, provides accurate and timely information for tackling MRSA and informs trusts where improvements should be targeted -

CHKS Ltd, the leading provider of analytical benchmarking to the NHS, has today launched its MRSA Diagnostic Audit programme to clearly present the incidence and distribution of hospital-acquired infection. To ensure relevance to clinicians and managers, the programme demonstrates the clinical impact (by location, case mix and outcome), as well as the organisational consequences in bed use and costs.

A key feature of the MRSA Diagnostic Audit includes the identification of incidence of infection, with immediate, on-line access to patient level information. A data quality report of the trust's MRSA dataset is also provided along with indication of the clinical impact and organisational consequences and peer group comparison. Presented in control chart form, data analysis identifies where infection rates deviate from the benchmarked standard level, to illustrate a Trust's performance and signal where attention and action are required.

CHKS' Chief Executive, Graham Harries, comments:

"Maintaining low rates of infection is vital to the successful and timely recovery of all patients and Chief Executives have a legal duty to identify, assess and control the risk of infection, for the benefit of patients and staff. The MRSA Diagnostic Audit enables a Trust to do this by identifying the incidence of infection, providing easy access to patient-level data, indicating the distribution and trends of infection across a trust, improving the quality of the data, providing accurate and timely information for tackling MRSA and by informing trusts where improvements should be targeted."

The MRSA Diagnostic Audit programme links data from infection control departments to in-patient data. This includes a data quality report of a trust's MRSA dataset and an updated control chart showing the clinical and organisational impact of MRSA. This highlights MRSA rates by admission type, specialty and consultant; the rate of patients admitted with MRSA; the top five isolation sites; and mortality rates of infected patients.

CHKS Ltd provides comparative healthcare information to NHS Trusts and the independent healthcare sector. Our aim is to help healthcare organisations to improve the service they provide to patients, through data analysis, benchmarking and interpretation.

With 15 years' experience of working solely with the healthcare sector and currently assisting over 120 Acute NHS Trusts, the Independent Sector and Primary Care organisations, CHKS has developed a portfolio of programmes which address key issues facing the clinicians and managers of today's NHS, while assuring and improving data quality. Our work focuses on clinical governance, performance management, clinician appraisal and service reconfiguration.

CHKS Ltd
1 Arden Court,
Arden Road, Alcester,
Warks,
B49 6HN
United Kingdom
sales@chks.co.uk
Tel : 01789 761600
Fax : 01789 764608

• Additional
• References
• Citations